Literature DB >> 9719603

Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors.

A P Tamiz1, E R Whittemore, Z L Zhou, J C Huang, J A Drewe, J C Chen, S X Cai, E Weber, R M Woodward, J F Keana.   

Abstract

A series of bis(phenylalkyl)amines, structural analogues of ifenprodil and nylidrin, were synthesized and tested for antagonism of N-methyl-D-aspartate (NMDA) receptors. Potency and subunit selectivity were assayed by electrical recordings in Xenopus oocytes expressing three binary combinations of cloned rat NMDA receptor subunits: NR1A expressed in combination with either NR2A, NR2B, or NR2C. The bis(phenylalkyl)amines were selective antagonists of NR1A/2B receptors. Assayed under steady-state conditions, the most potent of these, N-[2-(4-hydroxyphenyl)ethyl]-5-phenylpentylamine hydrochloride (20), has an IC50 value of 8 nM and >1000-fold selectivity with respect to NR1A/2A and NR1A/2C receptors. The structure-activity relationship of the bis(phenylalkyl)amine series indicates that the piperidine ring and alkyl chain substitutions common to NR2B-selective antagonists such as ifenprodil, CP 101,606, and Ro 25-6981 are not necessary to generate potent and selective ligands. The primary determinants of potency are the phenolic OH group, acting as a hydrogen bond donor, the distance between the two rings, and an electrostatic interaction between the receptor and the basic nitrogen atom. This study provides a framework for designing structurally novel NR2B-selective antagonists which may be useful for treatment of a variety of neurological disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9719603     DOI: 10.1021/jm980235+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  Control of assembly and function of glutamate receptors by the amino-terminal domain.

Authors:  Kasper B Hansen; Hiro Furukawa; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2010-07-21       Impact factor: 4.436

3.  Molecular modeling of N-terminal domains of NMDA-receptor. Study of ligand binding to N-terminal domains.

Authors:  I G Tikhonova; I I Baskin; V A Palyulin; N S Zefirov
Journal:  Dokl Biochem Biophys       Date:  2004 Jul-Aug       Impact factor: 0.788

4.  The micromolar zinc-binding domain on the NMDA receptor subunit NR2B.

Authors:  Julie Rachline; Florent Perin-Dureau; Anne Le Goff; Jacques Neyton; Pierre Paoletti
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

5.  E-p-methoxycinnamic acid protects cultured neuronal cells against neurotoxicity induced by glutamate.

Authors:  So Ra Kim; Sang Hyun Sung; Young Pyo Jang; George J Markelonis; Tae H Oh; Young Choong Kim
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

6.  Nafamostat and sepimostat identified as novel neuroprotective agents via NR2B N-methyl-D-aspartate receptor antagonism using a rat retinal excitotoxicity model.

Authors:  Masahiro Fuwa; Masaaki Kageyama; Koji Ohashi; Masaaki Sasaoka; Ryuichi Sato; Masami Tanaka; Kei Tashiro
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.